Amgen | Capitalisation Boursière



Market Capitalization Changement Date
AbbVie USD 327.88B 42.76B 2025-06
Agios Pharmaceuticals USD 1.93B 234M 2025-06
ALKERMES USD 4.72B 725M 2025-06
Amgen USD 150.13B 17.37B 2025-06
Biogen USD 18.41B 1.62B 2025-06
BioMarin Pharmaceutical USD 10.54B 3.01B 2025-06
Bristol-Myers Squibb USD 94.2B 29.9B 2025-06
Eli Lilly USD 738.79B 2.87B 2025-06
Genmab DKK 80.88B 7.82B 2025-06
Gilead Sciences USD 137.91B 1.77B 2025-06
GlaxoSmithKline GBP 56.24B 4.11B 2025-06
Glaxosmithkline USD 82.21B 2.63B 2025-09
Incyte USD 13.18B 1.46B 2025-06
Ionis Pharmaceuticals USD 6.29B 1.49B 2025-06
J&J USD 366.71B 32.94B 2025-06
Merck USD 198.77B 27.1B 2025-06
Moderna USD 10.67B 290M 2025-06
Neurocrine Biosciences USD 12.44B 1.5B 2025-06
Novartis CHF 256.18B 64.49B 2025-06
Novartis USD 258.67B 24.42B 2025-09
Pfizer USD 137.53B 6.19B 2025-06
PTC Therapeutics USD 3.87B 148M 2025-06
Regeneron Pharmaceuticals USD 55.87B 13.47B 2025-06
Sanofi EUR 100.06B 25.78B 2025-06
Sarepta Therapeutics USD 1.68B 4.51B 2025-06
Takeda JPY 7.04T 19.15B 2025-06
Teva Pharmaceutical Industries ILS 65.36B 1.34B 2025-06
Ultragenyx Pharmaceutical USD 3.44B 38M 2025-06
Vertex Pharmaceuticals USD 114.33B 10.31B 2025-06


Amgen Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Sep 2025.